P3 Health Partners Inc.
PIII · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.02 | -0.00 | -0.08 |
| FCF Yield | -337.09% | -62.63% | -167.64% | -23.87% |
| EV / EBITDA | -0.81 | -2.59 | -0.11 | -1.31 |
| Quality | ||||
| ROIC | -92.40% | -30.33% | -246.15% | -0.46% |
| Gross Margin | -9.66% | 2.50% | -9.05% | 99.86% |
| Cash Conversion Ratio | 0.35 | 0.41 | 0.47 | 0.42 |
| Growth | ||||
| Revenue 3-Year CAGR | 12.66% | 25.72% | 28.81% | 63.63% |
| Free Cash Flow Growth | -41.45% | 39.30% | -83.53% | -153.91% |
| Safety | ||||
| Net Debt / EBITDA | -0.64 | -1.06 | -0.06 | 0.27 |
| Interest Coverage | -14.46 | -10.50 | -136.87 | -2,942.53 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -0.01 |
| Cash Conversion Cycle | 15.48 | 22.11 | 24.00 | -31,450.52 |